BREAKING
Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 4 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 5 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 8 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 11 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 14 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 16 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 16 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 17 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 18 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 4 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 5 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 8 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 11 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 14 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 16 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 16 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 17 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 18 hours ago
ADVERTISEMENT
AlphaGraphs

Key highlights from Thermo Fisher’s (TMO) Q3 2023 earnings results

Thermo Fisher Scientific Inc. (NYSE: TMO) reported third quarter 2023 earnings results today. Revenue dropped 1% year-over-year to $10.57 billion. Organic revenues fell 3%. Net income attributable to Thermo Fisher Scientific Inc. was $1.71 billion, or $4.42 per share, compared to $1.49 billion, or $3.79 per share, last year. Adjusted EPS rose 12% to $5.69. […]

$TMO October 25, 2023 1 min read

Thermo Fisher Scientific Inc. (NYSE: TMO) reported third quarter 2023 earnings results today.

Revenue dropped 1% year-over-year to $10.57 billion. Organic revenues fell 3%.

Net income attributable to Thermo Fisher Scientific Inc. was $1.71 billion, or $4.42 per share, compared to $1.49 billion, or $3.79 per share, last year. Adjusted EPS rose 12% to $5.69.

For the full year of 2023, the company expects revenue of $42.7 billion and adjusted EPS of $21.50.

Prior performance

ADVERTISEMENT